For Providers

Training Opportunity:  You Call the Shots

The Florida Immunization Section is pleased to share the Centers for Disease Control and Prevention’s (CDC) new training courses. You Call the Shots is an interactive, web-based immunization training course. It consists of a series of modules that discuss vaccine-preventable diseases and explains the latest recommendations for vaccine use. Each module provides learning opportunities, self-test practice questions, reference and resource materials and an extensive glossary.

This free course is available on the CDC’s Vaccine and Immunizations website at: http://www.cdc.gov/vaccines/ed/youcalltheshots.htm.

This course is intended for nurses, nursing students, medical assistants, pharmacists and other health professionals who provide immunizations. Continuing education credit is available for the individual modules to physicians, nurses, health educators, and pharmacists.  

Modules now available:

  • Hepatitis A
  • Vaccine Storage and Handling
  • Vaccines for Children (VFC)
  • Understanding the Basics: General Recommendations on Immunization
  • Diphtheria, Tetanus, and Pertussis (DTaP)
  • Tetanus, Diphtheria, and Pertussis (Tdap)
  • Human Papillomavirus
  • Polio
  • Influenza
  • Haemophilus influenza type b (Hib)

Coming soon:

  • Hepatitis B
  • Measles, Mumps, and Rubella
  • Meningococcal
  • Pneumococcal
  • Varicella
    ——————————————————

From Florida’s Immunization Section – July 26, 2013
The latest news from the CDC regarding HPV Vaccination in the US-

Human Papillomavirus Vaccination Coverage Among Adolescent Girls, 2007–2012, and Postlicensure Vaccine Safety Monitoring, 2006–2013 — United States

 We are pleased to share the following with our immunization partners.  On July 26, 2013, the Centers for Disease Control and Prevention released Human Papillomavirus Vaccination Coverage Among Adolescent Girls, 20072012, and Postlicensure Vaccine Safety Monitoring, 20062013 United States (Morbidity and Mortality Weekly Report (MMWR)July 26, 2013 / 62(29);591-595) The complete report is available online at http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6229a4.htm?s_cid=mm6229a4_w.

This report summarizes national HPV vaccination coverage levels among adolescent girls aged 13–17 years from the 2007–2012 National Immunization Survey-Teen (NIS-Teen) and national postlicensure vaccine safety monitoring.

Since mid-2006, a licensed human papillomavirus (HPV) vaccine has been available and recommended by the Advisory Committee on Immunization Practices for routine vaccination of girls at ages 11 or 12 years. Based on results of the 2011 National Immunization Survey-Teen, only 53.0% of girls aged 13–17 years received 1 dose of HPV vaccine, and only 34.8% received all 3 doses of the HPV vaccine series.

Vaccination coverage of adolescent girls remained unchanged in 2012; only 53.8% of girls received 1 dose of HPV vaccine, and only 33.4% received all 3 doses of the series. Among unvaccinated girls, 84% had a health-care encounter in which they received a vaccine but not HPV vaccine. National safety monitoring data continue to indicate that the quadrivalent HPV vaccine is safe.

Despite the availability of safe and effective vaccines, many girls remain unprotected against HPV infections. Improving practice patterns so that health care providers and their staff members use every opportunity to offer HPV vaccines and are well-equipped to address questions from parents is necessary to reduce HPV-attributable cancers further.

By increasing 3-dose HPV vaccination coverage to 80%, an estimated additional 53,000 cases of cervical cancer could be prevented over the lifetimes of those aged ≤12 years. For every year that increases in coverage are delayed, another 4,400 women will go on to develop cervical cancer. Improving practice patterns and clinical skills so that health-care providers are well-equipped to address questions from parents and are committed to using every opportunity to strongly recommend HPV vaccination is necessary to achieve potential reductions in HPV-attributable cancers.

Although HPV vaccination coverage has lagged behind that of other vaccines recommended for adolescents, coverage among adolescent girls increased each year during 2007–2011; 2012 is the first year with no observed increase. In 2012, only 53.8% of girls had received ≥1 dose of HPV vaccine, and only 33.4% had received all 3 doses of the series. Approximately one quarter of surveyed parents did not intend to vaccinate their daughters in the next 12 months. Missed vaccination opportunities remain high. Every health care visit, whether for back-to-school evaluations or acute problems, should be used to assess teenagers’ immunization status and provide recommended vaccines if indicated.

Approximately 79 million persons in the United States are infected with HPV, and approximately 14 million will become newly infected each year. Some HPV types can cause cervical, vaginal, and vulvar cancer among women; penile cancer among men; and anal and some oropharyngeal cancers among both men and women. Other HPV types can cause genital warts among both sexes. Each year in the United States, an estimated 26,200 new cancers attributable to HPV occur: 17,400 among females (of which 10,300 are cervical cancer) and 8,800 among males (of which 6,700 are oropharyngeal cancers).

This report highlights three areas that need to be addressed to improve HPV vaccination coverage.

  • Healthcare providers must increase the consistency and strength of HPV vaccination recommendations.  CDC has recently developed a tip sheet (available at http://www.cdc.gov/vaccines/who/teens/for-hcp-tipsheet-hpv.html) to help providers respond to parents’ questions and communicate strong, clear HPV vaccination recommendations.
  • Missed vaccination opportunities need to be reduced:  The 2012 NIS-Teen shows that 84% of unvaccinated girls had a healthcare encounter where another vaccine was administered.

Please distribute this important information to colleagues, members, coalitions, and partners who provide or have an interest in immunizations. Please place this information prominently on your website.   Contact Laura Rutledge, RN regarding vaccine recommendations at (850) 245-4342.

Charles H. Alexander, Administrator
Immunization Section
Bureau of Communicable DiseasesDivision of Disease Control and Health Protection